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INTRODUCTION
Blastomyces dertnatitldis causes disease in man with 
several possible presentations: subclinical-asymptomatic,
acute pneumonia, chronic pulmonary, and/or a progressive 
systemic disease which may affect virtually any organ in the 
body. The disease was first described by Gilchrist in 
1894 as being of protozoan origin (27), but he soon identified 
the agent as fungal (28), He and Stokes gave the causative 
organism its current name (29). Further information regarding 
the disease and its history can be found in recent reviews 
and texts (10, 25, 66),
The diagnosis of the disease is currently most 
reliably made by direct culture of the organism from 
clinical specimens. Serological and skin tests are available, 
but negative tests do not rule out the disease and positive 
tests do not confirm it (10, 25). This situation stems 
from the lack of a Blastomyces test antigen which displays 
sensitivity and selectivity, and this comprises the major 
serological problem in blastomycosis.
This has been compiled in the belief that the absence 
of a comprehensive treatment of the antigens of B. dermatitidis 
has discouraged a coherent study of these antigens. In the
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hope of redressing this problem, the following four goals 
have been established: to provide a complete history of the
work in this area; to identify and discuss the most promising 
antigens isolated to date; to encourage protracted, in-depth 
research of these antigens; and to stimulate research to 
isolate and identify new antigens of diagnostic and analytic 
interest.
Much of the information is arranged in tabular form 
to allow comparisons to be made more easily. This format 
also allows a quicker historical survey and evaluation of 
progress in each area. The major experimental data included 
in these tables are the sensitivity and specificity 
of the antigen. Sensitivity is expressed as the percentage 
of known cases accurately identified. Specificity is 
expressed as the percentage of cross-reactions which 
inaccurately identify other mycoses as blastomycosis. The 
optimum, then, is to have 100% sensitivity (all true cases 
identified) and 0% cross-reactions (no reactions occur 
between the antigen and heterologous cases). The effectiveness 
of a particular antigen as a diagnostic indicator, and its 
comparison with other antigens, can be rapidly assessed by 
determining how closely it approaches this optimum 
sensitivity-specificity combination.
Since the emphasis of this review is on the antigens 
themselves, many reports of the use of these antigens for 
epidemiologic, immunologic, and diagnostic purposes have 
been omitted. Included, for the most part, are only those
studies engaged primarily in the evaluation of an antigen 
or in the comparison of multiple antigens.
ANTIGENS
Blastomycin
Skin-test. A most popular early antigen of B. 
dermatitidis was blastomycin, the culture filtrate obtained 
after growing the organism in the mycelial phase for periods 
ranging from weeks to months. The interest in this fraction 
is understandable since histoplasmin, the corresponding 
antigen from Histoplasma capsulatum, showed such success 
as an epidemiologic tool in skin-testing surveys. The 
history of blastomycin as a skin-test agent is detailed in 
Table 1.
E. R. Long is the first on record to use the term 
"blastomycin" (48). His work with guinea pigs showed 
blastomycin to be of no use in skin-testing but 100% 
effective in identifying infected animals in testes-testing. 
He conducted no cross-reaction studies, however, so that 
the major shortcoming of blastomycin was not documented until 
the work of Emmons et (26).
Howell's evaluation of blastomycin remains probably
the most extensive conducted (34). He documented the
effectiveness of several lots of antigen, dilutions, and
groups of infected guinea pigs. Skin-test reactivity varied
widely with all three. Undiluted antigen elicited reactions
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TABLE 1
BLASTOMYCIN; SKIN-TEST
DATE-REFERENCE SUBJECT
1926 Long (48) g-pig^
1945 Emmons + (26)^ g-pig
patients
1947 Howell (34) g-pig
1963 Balows (4) patients
1964 VA Study (74) patients
1974 Cox/Làrsh (13) g-pig
1976 Lancaster + (45) g-pig
SENSITIVITY
100%
0%
88% (7/8)4
88% (29/33) 
4% (1/25) 
50%
37% (20/54) 
65% (36/55)
100% (16/16) 
55%
0%
CROSS-RXS REMARKS
100% (8/8) 
97% (34/35)
12% (5/40)
40% (12/30) 
74% (23/31)
0% (0/16) 
0%
25%
testes-test reactions 
skin-test reactions
best of a range, see text
commercial blastomycin 
isolate "KCB" preparation
F fraction / isotachophoresis 
B fraction fractions from 
G fraction BPD
1) Unless otherwise stated, all antigen preparations were crude culture filtrates from mycelial cultures
2) guinea-pig
3) - = not reported or not done
4) indicates: number positive/number tested.
5) "+" indicates "et al.” in this and subsequent tables
8in 90% (9 of 10) normal animals, but this disappeared when 
dilutions greater than 1:10 were injected. Above this 
dilution factor, sensitivity ranged from 6-88% and specificity 
from 0-84%. He concluded that yeast phase antigens were 
superior to the filtrate preparations in both respects.
In 1950, Martin reported that of 972 patients tested, 
none of whom were known to have blastomycosis, 15 were 
skin-test positive to blastomycin but that 13 of these 
reacted with histoplasmin as well (in: 53). He later mentioned 
that, due mainly to this extensive cross-reactivity, 
blastomycin was used primarily as a control antigen in 
studies of histoplasmosis and coccidiodomycosis (53).
The reports of Balows and the VA study regarding the 
insensitive nature of blastomycin seemed to put to rest hopes 
of ever using this fraction diagnostically (4, 74). Cox and 
Larsh followed with the conclusion that the yeast-phase 
antigens were more specific (13). However, Lancaster 
and Sprouse fractionated B. dermatitidis KCB blastomycin 
by an unpublished gel chromatography procedure to give what 
they termed BPD —  blastomycin protein derivative (45).
Isoelectric focusing and isotachophoresis revealed 
BPD to be composed of 8 and 6 components, respectively.
Nine fractions were isolated from BPD by isotachophoresis, 
three of which are recorded in Table 1. Fractions F and 
G were intermediate-migrating proteins and fraction B 
migrated rapidly. It is surprising that the F and B 
fractions elicited skin test reactions only in infected
animals, though with different sensitivities (100% and 
55%, respectively). The G fraction reacted only with H, 
capsulatum-infected animals and so may be one of the 
culprits in the cross-reactive nature of blastomycin, 
especially with histoplasmosis sera. The excellent results 
obtained with the ? fraction have not been followed by 
additional studies, and its possibilities and nature 
remain unknown.
Complement fixation. Blastomycin was found to be 
as poor an antigen in complement-fixation tests as in skin 
tests. The studies evaluating this role are given in Table
2. Overall, the best sensitivity that can be expected is 
50%. Virtually no studies have been reported for the 
antigen's cross-reaction rate, though its low sensitivity 
is enough to disqualify it for diagnostic use.
Precipitation. The advantage in using precipitin 
tests, and especially the Ouchterlony method, for testing 
suspect sera is that not only does a positive or negative 
reaction occur, but precipitin reactions can often be 
differentiated by the location of the resulting bands. The 
sensitivity of blastomycin in precipitin tests is outlined 
in Table 3, and shows a slight advantage over skin-testing 
or complement-fixation.
Keeney and Eriksen prepared an ammonium sulfate- 
precipitated fraction of blastomycin and reported precipitin 
bands against 1:2 or 1:4 dilutions of infected guinea pig 
sera (43). Pates followed the course of precipitin formation
TABLE 2
BLASTOMYCIN: COMPLEMENT-FIXATION
DATE-REFERENCE SUBJECT SENSITIVITY CROSS-RXS REMARKS
1948 Tenenberg + (73) g-pig 46% (6/13) 0% (0/3)
1953 Campbell + (9) patients - - cross-rxs with heterologous 
sera higher than homologous
1964 VA Study (74) patients 49% (51/105) 
41% (56/136) -
1967 Busey/Hinton (7) patients 50% -
TABLE 3
BLASTOMYCIN: PRECIPITATION TESTS
DATE-REFERENCE SUBJECT SENSITIVITY CROSS-RXS REMARKS
1948 Pates (58) g-pig low
56%
100%
84%
84%
0%
2 weeks after infection 
3 - 5  weeks after infection 
7 - 9  weeks after infection
1961 Abernathy + (1) patients 77% - all cross-rxs distinguishable 
by banding pattern
1967 Busey/Hinton (7) patients 50% - 9% of patients were positive
to mycelial filtrate only
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in guinea pigs over a nine-week period (58). Blastomycin 
had extremely low sensitivity and high cross-reactivity 
in the early stages of the infection. This situation was 
reversed in later time periods to the point that the 
antigen was 100% accurate in identifying infected animals. 
These results complement Howell's observations (34) 
that the sensitivity of blastomycin in skin-testing varies 
with the sensitivity of the animal. This situation may 
make blastomycin of some use in following the course of the 
disease but of little use in rapid or accurate diagnosis.
The report by Abernathy and Heiner points out the 
advantage of the precipitin test since, in an undisclosed 
number of crossr-reactions, false positive reactions could 
be distinguished by the banding pattern (1). That 
blastomycin may still be of some, though not ideal, use 
as a precipitin antigen was documented by Busey and Hinton's 
finding that 9% of the patients studied were identified 
only with this preparation to have blastomycosis (7).
The use of immunoelectrophoresis to separate the 
components of blastomycin into a greater number of well- 
defined precipitin bands has allowed a more detailed 
comparison of its immunologic relations with other fungal 
antigens. Andrieu et al. identified 18 separate antigens 
in a blastomycin preparation, 13 of which were held in 
common with a similar preparation of H. capsulatum (2).
One of these common precipitin bands showed catalase 
activity. In a similar study, Kashkin et al. identified
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6 separate antigens by iimnnnoelectrophoresis, all of which 
were common to culture filtrates of either H. capsulatum or 
Coccidiodes immitis (39). Gel electrophoresis of their 
blastomycin revealed 6 proteins, 4 glycoproteins and 1 
nucleoprotein, out of which only one protein was absent 
in antigen preparations of the other two fungi.
Huppert et have recently tested blastomycin 
against an anti-coccidiodin reference serum (35). This 
group has found that blastomycin shares 12 antigens with 
coccidiodin, 3 with spherulin, 6 with an alkali-soluble 
water-soluble (ASWS) extract of C . immitis, 9-10 with 
histoplasmin, and 6 with ASWS from H. capsulatum. These 
numbers are obviously minimums since another reference 
serum, or sera raised to antigens other than coccidiodin, 
could show additional common components.
The extensive similarities between the mycelial 
cluture filtrates of all these fungi make it somewhat 
surprising that they should exhibit anything less than 
100% cross-reactivity with heterologous sera. The crudity 
of the preparations is of course the complicating factor.
A purified fraction of blastomycin has shown 100% 
sensitivity with no cross-reactions in skin-testing 
guinea pigs (45), but no purified preparations have been 
used in the precipitin test.
Other tests. Attempts to use blastomycin in 
agglutination tests have uniformly failed. The earliest 
record of such studies is that of Hektoen (in: 62, p. 502).
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He tested sera from immunized dogs and found that 
undiluted sera agglutinated whole organisms, but only 
after several hours. Sera from other mycotic cases, 
though, also showed slight agglutinating ability. In 
rabbits only faint agglutination was observed.
Saslaw and Campbell attached the antigen to collodion 
particles. Agglutination was only weak with known positive 
sera and often greater with heterologous sera. They also 
found a great variation in activity among antigen lots (68). 
Martin later reported that 65% of the sera from normal 
medical students would agglutinate erythrocytes sensitized 
with Blastomyces material if the test was made sensitive 
enough to react with positive cast sera (52).
Utilizing the lymphocyte transformation assay, Cox 
reported that 13 of 13 patients with positive histoplasmin 
reactions cross-reacted with blastomycin, although lower 
total counts were obtained. Slightly fewer cross-reactions 
occurred with sera from patients with coccidiodomycosis 
(11). This assay is probably the most sensitive of those 
discussed so far. This sensitivity may cause the test to 
react more consistently with the antigens shared among the 
crude filtrates of these fungi, and thereby exhibit a 
greater rate of cross-reactivity than the other tests 
described.
Whole Yeast Cells 
Skin-test. Whole yeast cells have not been used
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extensively in skin-testing. The history of that work is 
given in Table 4. The sensitivity can be seen to have 
varied widely among the studies, and testing for specificity 
has been minimal. The 1947 report of Howell is the same 
as that in Table 1 for blastomycin (34). He concluded 
that the yeast antigen was more sensitive, and more 
consistently so, than the culture filtrate, although the 
variations due to a particular lot, dilution, and animal 
sensitivity remained. The tabulated value for his work is 
for the 1:1000 dilution of his stock. At 1:100, sensitivity 
increased to 90% and the number of cross-reactions to 
89%. At 1:2000, no cross-reactions were observed, but the 
sensitivity dropped to 63%.
Complemeht-fixation. In the first attempt at 
complement-fixation (CF) using whole yeast, Davis found 
them to be anti-complementary and so abandoned the test 
(15). This and further history is shown in Table 5.
In 1926, Mellon tested B, dermatitidis in various 
morphologic states. Infections with mycelial fragments, 
conidia, yeast, or in-between states gave mixed CF titers 
among the homologous and heterologous antigens (55).
Salvin noted that the yeast gave a more sensitive test 
than culture filtrates but that adsorption studies 
indicated a very high cross-reactivity (66).
The breakage of cells as reported by Dulaney may 
have given excellent sensitivity by releasing cytoplasmic 
material (21), His use of this material in precipitin
TABLE 4
WHOLE YEAST CELLS: SKIN TEST
DATE-REFERENCE SUBJECT SENSITIVITY CROSS-RXS REMARKS
1911 Davis (15) patients 50% (1/2) -
1926 Long (48) g-pig 0% -
1936 Martin/Smith (54) patients 67% (2/3) - heat-killed yeast
1940 Peck + (61) patients 100% (2/2) - phenol-killed yeast
1947 Howell (34) g-pig 84% 8% best of a range, see
TABLE 5
WHOLE YEAST CELLS: COMPLEMENT-FIXATION
DATE-REFERENCE 
1911 Davis (15)
1925 Rebaudi (in: 50)
1926 Mellon (54)
1930 Dulaney (21)
1935 Martin (50)
1936 Martin/Smith (54)
1949 Salvin (66)
1950 Martin (51)
1964 Busey (55)
SUBJECT
g-pig
patient
rabbit
rabbit
patients
patients
rabbit
patients
patients
SENSITIVITY
+ (1/1)
100% (6/6) 
75% (3/4)
67% (4/6) 
74% (68/92)
71% (5/7) 
47% (8/17)
50% (40/80)
CROSS-RXS
0%
74% (77/104)
REMARKS
found anti-complementary
formalin-killed cells in 
differing morphologic states; 
mixed results
mortar-ground yeast
killed or live yeast,
0.3% suspension
mortar-ground yeast
formalin-killed yeast;
1:8 titer or higher = pos
"cutaneous" cases 
systemic cases
18
tests (sensitivity, 4 of 6) was probably also related to 
these components.
Overall, the information gained using whole yeast 
cells in skin and CF-testing has been more valuable in 
arguing for the superiority of the yeast phase versus the 
mycelial phase than it has been in diagnostic or epidemiologic 
work.
Yeast Fractions 
The above review should clearly highlight the 
necessity of moving from crude to more purified antigen 
preparations if both sensitivity and specificity are to be 
improved. With the exception of the fractionation of 
blastomycin by Lancaster and Sprouse (45), most effort 
has been directed toward the yeast phase of B. dermatitidis.
As noted above, comparisons between mycelial and yeast 
preparations generally identified the yeast as the more 
sensitive agent. In addition, since the yeast is the parasitic 
form, it has seemed more logical to look for useful antigens 
in this phase.
In attempting to prepare more defined antigens, 
four general sources have been investigated —  the filtrate 
or aqueous extracts of whole cells, the cell wall, the 
cytoplasm, and ethanol-precipitates of various preparations. 
These will be presented in the order of their historical 
appearance.
Ethanol-precipitates. The first antigen fraction to
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be recorded as used in the serology of Blastomyces was an 
ethanol (EtOH)-precipitate prepared by H. T. Ricketts for 
precipitin tests (in: 15). The history of these fractions 
dates from then to the present as summarized in Table 6.
Using the same antigen, Davis reported precipitin 
titers ranging from 1:7 to 1:20 in 69% of his infected 
animals (15), The cross-reaction figure in the table is 
for normal guinea pigs which he found to have titers of 1:3 
to 1:10 when positive. Neuber and Rohlich reported positive 
CF results with one patient’s serum (in: 50), and Peck 
et al. latter found the 44-60% EtOH fraction to be the most 
sensitive for that purpose (61). They reported the presence 
of a mannose-containing polysaccharide in their precipitates, 
but this was not further characterized. Such a precipitate 
was also found to be more specific than cytoplasmic 
antigens in skin-testing (52).
Dyson and Evans introduced a series of studies notable 
for the numbers of animals and antigen lots involved, as 
well as for the striking sensitivities and specificities 
they recorded (22, 23). Several lots of precipitated 
antigen gave 100% sensitivity with 0% cross-reactions in 
skin tests. It is of interest to note that these preparations 
originated from yeast culture filtrates. This success was 
repeated by Knight and Marcus who also reported that the 
average skin-test induration on B. dermatitidis-infected 
guinea-pigs was much greater than on H. capsulatum-infected 
animals —  6.0 vs 1.6 mm, respectively (44).
TABLE 6
YEAST FRACTIONS: ETHANOL-PRECIPITATES
DATE-REFERENCE SUBJECT PREPARATION^ TEST^ SENSITIVITY CROSS-RXS REMARKS
1905 Ricketts (in:15) g-pig cyto; 75% PPT - - distinct ppt seen
1911 Davis (15) g-plg cyto; 75% PPT 69% (22/32) 9% (2/22) x-rxs in normal pigs
ST 0% —
1940 Peck + (61) rabbit exoAg/A; 60% CF — — 44-60% fraction best
ST + (2/2) —
1948 Keeney + (43) rabbit exoAg/B; 75% PPT + (-)
1954 Dyson + (22) rabbit exoAg/B; 50% ST 100% (10/10) 0% (0/10) 2 antigen lots
; 67% ST 100% (13/13) 0% (0/15) 3 antigen lots
1955 Dyson + (23) rabbit exoAg/B; 67% ST 97% (29/30) 0% (0/36) 6 antigen lots
: ; 75% ST 72% (18/25) 0% (0/30) 5 antigen lots
g-plg ; 67% ST 100% (9/9) 0% (0/7) 10 microgram level
1958 Knight + (44) g-plg exoAg/B; 67% ST 100% (6/6) 0% (0/11)
1960 Marcus + (49) rabbit exoAg/B; 67% PPT + (1/1) — only homologous bands
CF + (1/1) + (3/3)
1961 Edwards + (24) human exoAg/B; 67% ST - , 38% (8/13) recruit survey
1977 Rippon + (63) patients exoAg/B; 84% PPT 90% (18/19) 0% (0/40) fresh sera only
1) Origin of antigen (cyto = cytoplasm; exoAg = acqueous extract. A, or broth filtrate, B);
% ethanol used to precipitate the fraction tested.
2) CF = complement-fixation; ST = skin test; PPT = precipitin test; ELISA = enzyme-linked immunoadsorbant 
assay.
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Edwards et surveyed 2131 recruits and found 21 
to be skin test positive (24). Eight of thirteen histoplasmin- 
sensitive recruits also reacted to blastomycin and this is 
the figure entered in the table. These results are somewhat 
misleading since the disease state of these recruits was not 
known, and so the true sensitivity of specificity of the 
antigen remains in doubt.
The most extensive precipitin trial with patient sera 
was performed recently by Rippon et (62). Excellent
sensitivity and specificity was reported when fresh sera 
were tested, Stored sera were virtually unusable. This 
group also found that the antigens derived from the "+" mating 
strains of the organism were uniformly more sensitive (100%) 
than those derived from the strain. In addition, a 
protein from this preparation was eluted from polyacrylamide 
gels and found to have esterase activity and to form a 
precipitin band of identify with the whole ethanol-precipitate. 
Thus the presence of antibodies to an active enzyme was 
demonstrated.
With this last exception, the ethanol-precipitates 
have not been characterized for the specific components 
responsible for such excellent results. Work by Young 
(K. D. Young, Ph.D. Thesis, University of Oklahoma, Norman, 
1980) has indicated that a component now known as the A antigen 
can be precipitated with the ethanol concentrations used by 
previous investigators. It is therefore very likely that the 
EtOH preparations that have been used could contain this
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particular component, the importance of which will be discussed 
below.
Cytoplasmic. Cytoplasmic antigens have been prepared 
in several ways, the most common being grinding of cells in 
a mortar. Bonification, and breakage via glass beads. Cell 
walls and debris were removed by centrifugation and the 
supernatant generally used without further purification.
This fraction was the first to be precipitated with EtOH, 
and its use as a crude preparation begun soon afterward by 
Eggers (in: 14), Table 7 presents the history of these 
fractions.
After an early beginning, a long lag occurred 
before Martin began investigating cytoplasmic antigens in 
1950 (51). He reported "good" results using a protein 
fraction for CF. A carbohydrate fraction fixed complement 
with rabbit, but not human, serum, while the protein 
fraction was effective with either. He later reported that 
the cytoplasm equalled or exceeded the sensitivity of whole 
yeast cells in CF (52). At the same time he reported good 
sensitivity of the fraction for skin-testing, but with an 
extremely high rate of cross-reactions. A much better 
showing was given by the extract of Dyson and Evans, but 
the small number of animals examined makes generalization 
questionable (22).
Campbell reported the testing of 50,000 sera from 
recruits (8), She noted that CF tests cross-reacted 
extensively with histoplasmin-positive sera, and that such
TABLE 7
YEAST FRACTIONS : CYTOPLASMIC
DATE'-REFERENCE SUBJECT PREPARATION TEST^ SENSITIVITY CROSS-RXS REMARKS
1906 Eggers (in:15) rabbit mortar PPT slight - 1 pos of "several"
1914 Stober (70) patients ground ST 50% (1/2) -
1953 Martin (52) rabbit
patients
II
g-pig
sonified
t l
VI
t l
CF
CF
AGGL
ST
+ (1/1) 
58% (40/69) 
0% (0/34) 
85% (11/13)
33% (5/15) 
83% (10/12)
PPT positive in 
rabbit & patient sera
1954 Dyson + (22) rabbit ground,HgO ST 100% (3/3) 20% (1/5) best preparation
1960 Campbell (8) recruits ground,NaCl CF
39% (/1238)
33% (/10,000) 
69% (/1238)
survey, not patients
1966 Kaufman (40) patients mortar CF 28% (8/21) 22% (2/9)
1973 Kaufman + (41) patients broken CF 41% (20/49) 77% (37/47)
1974 Cox/Larsh (13) g-pig broken ST 89% (24/27) 24% (4/17) 10-30K mol wt 
fraction best
1977 Rippon + (63) patients broken PPT 90% (18/20) 0% (0/40) fresh sera only
1979 Green + (30) patients broken PPT - - A antigen absent
1) As In Table 6; AG6L = agglutination.
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cross reactions were worse with the precipitin and 
agglutination tests. Martin described the cytoplasm as 
"not very specific" (53) and Kaufman et recorded the
very poor results shown in the table (40, 41). On the other 
hand. Odds et al. found this preparation more sensitive in 
CF tests than whole cells or cell walls (56), Kaufman 
et al. reported it to be the only fraction of sufficient 
sensitivity for CF (41).
The first real attempt at fractionating the cytoplasm 
seems to be that of Cox and Larsh (13). Four fractions 
were collected by ultrafiltration through membranes of 
decreasing pore size and tested for skin-test reactivity 
on guinea-pigs. The fraction between 10-30K molecular 
weight was shown to be the most active and least cross­
reactive of the four, This preparation was more specific 
than blastomycin. It was also more sensitive than an 
alkali-soluble water-soluble (ASWS) antigen (88%-vs-78%) 
but gave more cross-reactions (23%-vs-10%). These investigators 
concluded that the cytoplasmic preparation might be 
very useful if further purified. Rippon et reported a 
90% sensitivity in Ouchterlony precipitation with a crude 
preparation (63).
Green et reported that the A antigen of B. 
dermatitidis was absent in cytoplasmic preparations (30). 
However this study included only the one isolate, A373.
Later work by Young (K. D. Young, Ph.D. Thesis, University 
of Oklahoma, Norman, 1980) revealed that the presence of
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the A antigen in cytoplasmic preparations varied from 
isolate to isolate, and was associated with two distinct 
protein bands in polyacrylamide gel electrophoresis (PAGE).
Exoantigen. The term "exoantigen" was first 
coined by Standard and Kaufman to describe the antigenic 
material that could be extracted from whole yeast or 
mycelium by allowing it to stand in an acqueous solution 
for a period of days to weeks (69). These first applications 
were directed toward the identification of fungal cultures 
of H. capsulatum and C, immitis, but the antigens were 
soon used for serologic purposes as well.
The first mention of the exoantigens of B. 
dermatitidis was in 1978 (42). These extracts were 
subsequently used in serologic testing (30, 31). Several 
earlier investigations employed such extracts and 
so have been included in this section, the history of 
which is given in Table 8.
Peck et first reported the use of saline extracts 
of the yeast-phase of B. dermatitidis in 1940 (61). They 
gave no details in its reactivity, being more interested 
in their EtOH-precipitate, except to state that the two 
were probably equivalent antigens.
Martin tested saline extracts only superificially for 
CF activity, but reported good activity in agglutination 
studies and excellent sensitivity in skin-testing (52).
Busey and Hinton, and Kaufman tested a form of this type 
antigen by using yeast broth filtrates (7, 41). These had
TABLE 8
YEAST FRACTIONS: EXOANTIGEN1
DATE-REFERENCE SUBJECT PREPARATION^ TEST^ SENSITIVITY
1953 Martin (52) rabbit saline CF + (1/1)
patients II II - (0/1)
II II AGGL 75% (26/35)
g-plg II ST 92% (12/13)
1967 Busey + (7) patients broth flit. PPT 77% (64/80)
II I t CF 50% (33/65)
1973 Kaufman + (41) patients broth flit. PPT 59% (29/49)
1978 Kaufman + (42) - water,50X PPT 100% (56/56)
1980 Green + (31) patients (saline,DEAE- CF 70% (10/16)
f l cellulose) ELISA 92% (25/27)
II II PPT 52% (13/25)
g-plg II ST 100% (13/13)
1) Antigen prepared by sallne- or water-extractlon of whole cells;
CROSS-RXS
17% (2/12) 
33% (16/49)
34% (16/47) 
0% (0/99)
0% (0/5) 
20% (2/12)
0% (0/15)
REMARKS
cross-rxs distinguish­
able by band pattern
distinguish by pattorh; 
A and B bands named
Identification of 
cultures with antl-A 
serum
purified A antigen 
used In all tests
2) Extraction procedure.
3) As In Table 6.
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lower sensitivity and higher cross-reactivity than the 
acqueous extracts.
After it was recongized that specific antigens 
could be extracted from the fungi with water, Kaufman 
and Standard used this procedure to show that cultures of 
B. dermatitidis could be identified with 100% accuracy 
(42). Green et al, identified the A antigen, and a new 
D antigen, in the water-soluble fraction (30). Using this 
preparation in Immunoelectrophoresis, they removed specific 
precipitin arcs and by immunizing rabbits produced the 
first reference serum for the A antigen.
This reference serum was useful in monitoring further 
purification of saline extracts by anion exchange chromatography. 
With a purified A antigen fraction from this procedure, Green 
et al. reported a remarkably good combination of sensitivity 
and specificity in CF, the enzyme-linked immunosorbant assay 
(ELISA) procedure, and skin-testing (31). Although the 
ELISA test showed cross-reactions in 2 out of 12 patients 
with other mycoses, the titers were only 1:8, The only test 
to fall behind was the precipitin test which detected only 
half the known cases. However, the patient sera used for 
this study had been in storage, and the observation of 
Rippon et concerning the negative effects of serum
storage may explain this much lower sensitivity (63).
The emphasis of these exoantigen preparations has 
been directed mainly toward the characterization of that 
component termed the A antigen. This antigen of B.
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dermatitidis may be the best characterized and have the 
most diagnostic potential of all those studied to date.
This antigen will be described in more detail separately.
The A, Antigen. The A antigen was first named by 
Kaufman et al, as that antigen forming a precipitin line 
located nearer the antigen well (41). A "B" antigen was 
also described which formed nearer the well containing 
patient serum.
Palmer et a^, considered that precipitation with 
the A antigen was diagnostic for a current or recent case 
of blastomycosis, although a negative reaction was not 
conclusive proof of absence of the disease (57). That 
these preparations were not pure was first mentioned by 
Kaufman and Standard, who found that reference serum 
produced 2-3 precipitin bands in addition to the A band 
(42).
The first "A-only" reference serum was prepared by 
Green et aJ, as described earlier (30). Using this serum 
they monitored the purification and characterization of the 
A antigen. The antigen was found to be resistant to 
boiling for two minutes, and moderately resistant for 
periods up to 10 minutes. It was not degraded by trypsin, 
proteinases IV, V, or VII (Sigma), or nucleases. The 
protein^to-carbohydrate ratio of the preparation was 10:1. 
The active fraction could be eluted from anion exchange 
columns with 0,6 M NaCl (31),
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That this particular preparation still contained 
extraneous components was shown by Young (K. D. Young, Ph.D. 
Thesis, University of Oklahoma, Norman, 1980). Five prominent 
glycoprotein bands could be visualized in PAGE analysis 
using Coomassie blue, and a minimum of 20 additional proteins 
were detected by a more sensitive staining technique. The 
components associated with the A antigenic activity were 
identified by a combination of comparison with other antigen 
preparations and affinity chromatography. Two proteins, one 
a glycoprotein, were reported to be the active components.
These proteins may correspond to the two very closely 
located precipitin lines, which can be mistaken for a single 
band, in the A-antigen/reference A-antiserum system. That 
the reference serum was not monospecific was also evidenced 
by its formation of at least two additional precipitin 
lines to other antigen preparations.
The effect of this characterization may be to 
stimulate production of purer preparations, thus hopefully 
avoiding possible cross-reactions with future heterologous 
sera. At least, such characterization will allow sensitive 
monitoring of antigen preparations for the presence and 
purity of the A antigen.
The location and function of this antigen are still 
in doubt. It was reported to be present in the yeast cell 
wall, but absent from the cytoplasm (30). This conclusion 
was reached from studies of only two isolates of B, 
dermatitidis. Later work showed that the cytoplasm can
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contain substantial amounts of the A antigen, depending on the 
isolate (K.D. Young, Ph.D. Thesis).
The degree to which the A antigen has proven itself 
in diagnostic work and the extent of its characterization 
make it the most likely candidate for immediate serologic 
and immunologic use. However, further purification and 
analysis are required before even this single antigen of 
B. dermatitidis can be understood in terms of its 
relationship to the organism and to the disease.
ASWS. The alkali^soluble water-soluble (ASWS) 
fraction of the cell wall of B. dermatitidis was first 
referred to by Cox and Best (12). Comparison of this 
fraction from two isolates of different virulence revealed 
the compositions to be equivalent. The fractionation procedure 
for this antigen and its use in skin-testing was reported 
by Cox and Larsh (13), Overall, ASWS had somewhat lower 
sensitivity than cytoplasmic antigens but had a lower rate 
of cross-reactivity, also. Subsequent results using this 
preparation are summarized in Table 9.
The antigen was shown to be extremely sensitive in 
identifying infected guinea pigs by skin-test, macrophage 
migration inhibition (MI?) and lymphocyte transformation 
(LT) assays (17), The optimal dose was 100 micrograms, 
lower doses giving decreasing sensitivity. A similar 
study by Hall et al. repeated the excellent LT responses, 
and further established that the variation between two 
antigen lots was insignificant (32). Further animal studies
TABLE 9
YEAST FRACTIONS; ASWS^
DATE-REFERENCE SUBJECT TEST^ SENSITIVITY CROSS-RXS REMARKS
1974 Cox/Larsh (13) g-pig ST 56% (31/55) 0% (0/29) 48 hr: 10-30K mol wt fraction
II II 40% (22/55) 2% (1/51) 48 hr: whole ASWS
1976 Lancaster + (46) g-pig ST 100% (10/10) 0% (0/10) slowest peak in preparative
PAGE
1977 Deighton + (17) g-pig ST 88% (21/24) 7% (1/14) 100 ug
MIF 83% (10/12) 0% (0/10) II
LT 92% (12/13) 0% (0/11) II
1978 Hall + (32) g-pig LT 100% (28/28) 0% (0/8) 10 - 100 jjg
1979 Cox (11) human LT — 0% (0/11) coccidiodin-reactive subjects
t l II - 100% (13/13) histoplasmin-reactive subjects
1980 Hall + (33) g-pig ST
3
Var Var depends on infecting strain
II LT Var Var and strain used in antigen
II MIF Var Var preparation
1) ASWS = alkli-soluble, water-soluble cell wall antigen; prepared as in Cox and Larsh (13).
2) As in Table 6; plus, MIF = macrophage migration inhibition factor; LT = lymphocyte transformation assay.
3) Variable.
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revealed that the sensitivity and specificity of the antigen 
depended on the particular isolate used for animal sensitization 
(33). Of 3 isolates tested, skin-test sensitivity varied 
between 40-80%, and was correlated with the virulence of the 
infecting organism, The most virulent isolates elicited 
the greatest number of positive skin tests. The LT and MIF 
assays reacted well with antigens from all three isolates, 
but reflected the same type of variation among the three 
infected animal groups.
The success of these tests in animals has not been 
repeated in the one report with human subjects. Using the 
LT assay, Cox found that Blastomyces ASWS elicited reactions 
in 13 of 13 subjects with positive skin-tests to histoplasmin 
(11). She reported no cross-reactivity to 11 coccidiodin- 
sensitive subjects.
Only two attempts have been reported regarding the 
further purification of the ASWS antigen, Cox and Larsh 
found that the 10-30K molecular weight portion was slightly 
more sensitive in skin-tests than was the whole preparation 
(13). Lancaster and Sprouse isolated the slowest moving 
of four protein fractions in preparative PAGE and showed 
it to give optimum results in skin-testing guinea pigs (46). 
Neither of these fractions has been tested in patients.
The relationship of this antigen to other similar 
preparations from other pathogenic fungi has been investigated 
by Immunoelectrophoresis (35). Five precipitin lines formed
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between it and an anti-coccidiodin reference sernm. These 
five components were also uniformly present in every antigen
preparation from H. capsulatum and C. immitis that was tested,
These results highlight the fact that the ASWS fraction is
still only semi-pure.
The ASWS antigen is the only preparation of B.
dermatitidis that can be accurately and reproducibly
standardized on a weight basis (12, 13). It has shown
exceptional usefulness in skin-testing guinea pigs but
its usefulness in humans is still in question. Its
sensitivity to variations in the infecting organism may
tell more about the disease process and the organisms
themselves than about the disease state of the individual.
The cross-reactivity in humans may be due to the
multiple-component nature of the antigen, or it may reflect
some important common link between infections caused by the
pathogenic fungi. Either possibility will be more easily
answered by utilizing the current methods of further
purification mentioned above, and the devising of new
procedures.
Monoclonal Antibody Production 
The above discussions center around antigens 
purified by physical means and generally characterized 
by immunologic tests which contain multiple reactive 
components. An alternate approach is to purify specific 
antigens by immunological means, thereby partially combining
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the isolation and characterization steps, A method has 
been developed in the past few years whereby pure antibodies 
may be produced which are specific for only one antigenic 
determinant. This development opens the way for purification 
of components by attaching such specific antibodies to 
affinity gels.
The application of this "hybridoma" technology to 
isolation of components of B. dermatitidis has been 
recently reported (K. D. Young, PhD Thesis, University of 
Oklahoma, Norman, 1980), In this instance, one protein of 
a cytoplasmic preparation of B. dermatitidis was isolated 
by affinity chromatography. Neither the immunologic or 
the diagnostic importance of this antigen has been studied. 
The establishment of a cell line secreting antibody 
specific for this protein does, however, make its isolation 
and characterization capable of being standardized, and 
underlines the usefulness of this method in future work with 
the pathogenic fungi.
CHEMICAL COMPOSITION
The study of the above antigens' biological activity 
and that of their chemical nature must eventually merge 
if they are to be truly understood. The chemical composition 
of B. dermatitidis' yeast cell walls has been most deeply 
studied and will be presented first.
Cell Wall
General composition. The overall sugar content of 
yeast cell walls has been measured by several workers. The 
major hexose is glucose (12, 19, 36, 38), and major amino 
sugar is glucosamine (12, 36, 38), Glucosamine is present 
in a 1.5X greater amount in yeast than in mycelial walls 
(64), Lipid has been reported (36, 37), and in many cases 
has been removed prior to cell wall analysis without 
significantly affecting the values of other components 
(19, 61). Chitin content has been reported to be greater 
in more virulent isolates (12), and may comprise between 
24-43% of the cell wall (12, 19, 37). The yeast phase has 3 
times the amount of chitin as the mycelial phase (37).
Amino acids comprise 8-11% of the total composition (38).
Mannose constitutes only about 1% of the wall, but
seems to be a major component in several extracts (19, 38, 61)
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In one case, one-half of all the wall mannose appeared in 
an ethylenediamine-methanol-water soluble fraction (19), 
Mycelial walls generally contain more of this sugar (19). 
Galactose is also present in small amounts, often 
associated with mannose (37).
A recent study with fluorescent lectins has 
identified the following as present as terminal sugars: 
alpha-D-mannopyranose, beta-D-galactopyranose, 
beta-D-acetylgalactosamine, beta-D-N-acetylglucosamine, 
alpha-L-fucopyranose, and sialic and/or uronic acid (71).
In one instance, the similarity of the chemical 
compositions of the walls of B. dermatitidis and H. 
capsulatum cheraotype 11 was advanced as a possible reason for 
the extensive serologic cross-reactivity between these two 
organisms (19).
Glucan type. From the solubilities of wall material 
treated with alkali, Kanetsuna et al. calculated that the yeast 
glucan present was 95% alpha glucan and 5% beta glucan, both 
probably 1-3 linked (38). Later use of beta-1, 3-glucanase 
was uniformly ineffective in degrading yeast cell walls, 
suggesting that beta-1, 3-glucan was either absent or 
present in undectable amounts (16, 19, 56). A slight 
cytoplasmic disruption, though, was seen in whole cells treated 
in this manner which may indicate a very low presence of the 
beta glucan (56).
Lipids. Lipids have been reported to comprise from 
3-10% of the total yeast (20, 36, 59). Whole cells were 8-10%
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lipid (59), and a breakdown between walls and cytoplasm 
yielded 3% and 12-18% compositions, respectively (20).
Mycelium contained far less lipid in both fractions (20).
Peck and Hauser identified the lipid components 
isolated from whole cells (59). The phosphatide fraction 
comprised 24-34% of the total lipids and included the 
presence of carbohydrate, ethanolamine, and choline. 
Glycerophosphoric acid composed 3.1% of the total fraction, 
and fatty acids, 65%. The following fatty acids were 
present in these percentages of total lipids: oleic, 49.1%; 
palmitic, 8,2%; stearic, 4.2%; linoleic, 3.5%. An acetone- 
soluble fraction comprised 66-76% of total lipids and 
included 4% sterols (glycerol and ergosterol) and 88% 
fatty acids. These fatty acids were present; oleic, 55%; 
linoleic, 18,5%; palmitic, 9.7%; stearic, 4.8:.
Domer and Hamilton investigated the composition of
the walls alone (20). The greatest single component was
the triglyceride fraction. The most concentrated
phospholipids were phosphatidyl choline, phosphatidylethanolamine
and phosphatidylserine. Also present were diglycerides,
< - 
sterols, sterol esters, and free fatty acids. In the yeast
walls, oleic acid was predominate among the fatty acids,
while mycelial walls had an equal or greater amount of
linoleic acid. In the wall fraction, more oleic and less
linoleic acid was present in all lipid classes than in
cytoplasmic fractions.
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All the work discussed above analysed the easily 
extractable lipids. Peck et examined the cells after 
the removal of these and found the cells to be composed of 
an additional 5,7% firmly bound lipid fraction (60). These 
consisted of much the same components as described 
previously, but their relative abundance not mentioned.
Protein. In 1940, Peck et reported that the protein 
fraction of whole cells was the skin-test active fraction 
(61). Taylor later showed that protein could be removed from 
the cell wall of whole organisms by trypsin treatment, thereby 
proving that some protein is located on the wall's exterior 
(72). Total protein in the walls may vary from 5-10% (12,
37, 38). Mycelial walls have 3-4 times more protein content 
than yeast walls (30%-vs-7%; in: 37). Cox and Best also 
reported that the walls of a more virulent isolate were 
composed of twice as much protein than a less virulent isolate 
(10.5%-vs-5%; in; 12).
ASWS. Before the explicit naming of this fraction, 
Kanetsuna and Carbonell reported on the composition of an 
alkali-soluble, non-acetic acid-precipitable preparation 
from yeast walls (38), The fraction was 32% hexose, 0% 
amino sugar, and 0% amino acids. The major constituent 
seemed to be a polysaccharide of glucose:galactosermannose 
in a 1:5,2;6,8 ratio. This comprised most of the cell wall 
galactose and mannose, and was present in very small yield.
The polysaccharide composed of these three sugars was
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also detected in this fraction by Cox and Best (12), But 
although present in the original ASWS fraction, further 
purification of the carbohydrates by Azuma et al revealed 
the absence of any galactomannan (3). Whether this is a 
general phenomenon or is isolate-dependent is not known.
The hydrolysis of mannan-protein complexes is known to be 
one of the actions of alkali extractions (47), and so 
the appearance of this sugar in this fraction should be 
expected.
The absence of hexosamines in an ASWS preparation 
was later confirmed (64), but protein and amino acids were 
later detected (12, 14, 65). After treatment with alkali, 
yeast walls released twice as much protein as mycelial 
walls (65). The protein fraction most active in skin-testing 
was determined to be in the 10-30K molecular weight range
(13). PAGE analyses of ASWS have performed and the results 
are given in Table 10. These will be discussed below in 
relation to such analyses for several protein preparations.
PAGE Analyses
Polyacrylamide gel electrophoresis data of various 
antigen preparations are organized in Table 10. Bands have 
been lettered according to the results presented by Cox 
and Larsh (14). Placement of an Rf value in one band or 
another does not imply an identity of these components since 
the data are from several reports which used varying 
procedures.
TABLE 10 
PAGE ANALYSES OF ANTIGENS
BAND 50K 30K lOK 009BY ASWS ASWS COM-B KCB-B YF+ YF- MYC A-AG
2) 3) 3) 3) 4) 3) 5) 9.) 9) _6I _§I _71 8)
A 06* 04 04* 04* 05*
B 09* 07 06* 07 11 08* 08*
b 11 10 15
C 24* 21 23 24 24* 18*20*
22*
D 26 26 27 26*
£ 30 33 33 32 32 30 30* 29*
35 31
F 38 39 39* 43 42 40,44 40,43
46
G 49* 50 50 53* 53 49 50 54
H 63* 66 62* 65 68*
I 72 75 75 77 75 70 70 70 72
75
J 80 81 85
K 98 89 94 97* 99 99 99 95 97
1) Protein bands; = carbohydrate stainable also; values relative to
dye front, dye front = 100.
2) Band designations as in (14); use as a comparative guide only.
3) Cytoplasmic mol. wt. fractions as in (14); ASWS as in (14); 7.5% gels.
4) Cytoplasmic fraction of Young (Thesis); 14% gels; also had 9 additional 
proteins with Rf = 17,20,35,41,45,55,64,78,89.
5) ASWé as in (46); 5% gels.
6) "+" or strains of A. dermatitidis, as in (63); 8.5% gels.
7) As in (39); nucleoprotein at Rf = 31; 7.5% gels.
8) A antigen of Green et al. (31); data from Young (Thesis); 14% gels.
9) Commercial blastomycin (COM-B) or KCB-prepared blastomycin (KCB-B); 
as in (14); 7.5% gels.
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The greatest number of proteins was detected by 
Young in a cytoplasmic preparation (K. D. Young, Ph,D.
Thesis, University of Oklahoma, Norman, 1980). At least 
20 proteins could be identified with Coomassie blue 
staining, and others by a more sensitive silver stain.
Although the number of bands visualized in the 50K preparation
(14) was less than in 009BY, the arrangement of the major 
peaks was the same. The prominent A and B doublet and the 
G, H and I triplet were both present, as well as equivalent 
bands between them. In most cases in the table, protein 
staining was accomplished with Amido Black, which, since 
less sensitive than Coomassie blue, may account for many of 
the omitted proteins,
Cox and Larsh found four bands (A, B, C and F) 
to be consistently present in their skin-test reactive 
3OK fraction (14). One of these four, they concluded, 
was probably responsible for the activity. In a study on 
ASWS, Lancaster and Sprouse determined that the slowest 
moving band in their preparation was the active skin-test 
component (46). This band falls in the range of the B 
band of Cox and Larsh. Using immunofixation, it has also 
been noted that immune rabbit serum fixes, to the extent 
measurable with this technique, only the B band (K. D.
Young, unpublished observations). This band is also the 
only one common to 7 of the first 8 preparations in the 
table, which were skin-test reactive, though to varying 
degrees. No skin-test data was given for the remaining
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three preparations. This B band has been determined to be 
a glycoprotein, where tested, and the evidence seems to 
indicate that further effort in purifying this component 
would be valuable.
The major glycoproteins of the A antigen are 
recorded in Table 10. Also recorded is one additional 
protein (Rf =54) which only appeared in the A antigen after 
silver staining. The bands at Rf's 18 and 54 are those 
found to be active in Ouchterlony precipitin tests against 
a reference antir-A serum (K, D. Young, Ph.D. Thesis, 
University of Oklahoma, Norman, 1980). Neither of these can 
be unambiguously matched with proteins in the other 
preparations.
Although several antigens have been analyzed by 
PAGE, most of these have been preliminary characterizations 
of crude preparations. The two exceptions are the 
preparative work of Lancaster and Sprouse (46) and the 
use of PAGE to detect specific proteins removed by affinity 
chromatography (K, D. Young, PhD Thesis). The isolation 
and testing of the numerous components listed in Table 
10 would be useful in identifying more precisely the roles 
played by the various antigens.
Miscellaneous 
Extracellular enzymes. Since extracellular enzymes 
are potentially important antigens, the list of those 
associated with B. dermatitidis will be presented. The
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following have been detected: acid and alkaline phosphatase 
(5, 63), leucine amino peptidase, alpha-esterase (63), 
beta-1,3-glucanase, N-acetyl-beta-D-glucosaminidase, and 
alpha-D-mannosidase (16). Those absent are: alpha- or
beta- glucosidase and alpha- or beta-galactosidase (5, 16).
Two enzymes have definitely been shown to elicit 
antibodies in patient sera. A precipitin band showing 
catalase activity was reported by Andrieu et al. (2), 
and one with alpha-^esterase activity was identified and 
purified by PAGE (63).
Mannose-containing antigens. In the discussions 
above, mannose-containing components have been reported 
isolated in several instances. These instances are 
summarized since the fractions in which these are found 
often give excellent sensitivity and specificity. The 
component is generally a galactomannan, although glucose 
also may be present. Such carbohydrate compounds have 
been identified in ethanol-precipitates (39, 59, 61), in 
whole cells (71), and in the ASWS antigen (12, 19, 38). 
However, in this last antigen, additional purification of 
the carbohydrates revealed the absence of galactomannan (3) 
Since these compounds occur so frequently in reactive 
preparations, it seems worthwhile to specifically isolate 
them for further testing.
Virulence correlations. Although not directly 
related to antigenicity, it is of interest to review the
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factors which have been associated with the degree of 
virulence of B. dermatitidis. These are: increasing lipid
content (18), including phospholipid (12); increasing protein 
and chitin content (12); cell wall material minus protein 
(72); and decreasing alkali-soluble material (12). This 
latter observation has obvious relevance to the isolation 
and use of the ASWS antigen.
SUMMARY
"Without these tools (skin^test and complement 
fixation antigens for epidemiological, diagnostic, and 
prognostic use) we are at least 50 years behind in our 
defining of the disease blastomycosis" (63). This 
statement by Rippon et emphasizes the need for a well
defined antigen or group of antigens from Blastomyces 
dermatitidis, not only for the two tests named above, but 
for any serological or immunological test. Several different 
preparations have been reviewed which are beginning to 
approach the quality necessary for such a sensitive and 
specific antigenic tool. All of these require further 
characterization and, in most instances, purification.
One purified fraction isolated from blastomycin, the 
F fraction, has shown exceptional promise as a skin-test 
agent in guinea pigs but has not been further studied.
A 10-30K molecular weight fraction of the yeast cytoplasm 
has shown good reactivity, and contains a protein shown by 
PAGE to be common to several skin-reactive preparations.
This fraction has not been further purified.
An ASWS preparation has been partially characterized 
and shown to be especially sensitive and specific in animals, 
though not yet in humans. Purification of this fraction by
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PAGE has uncovered a highly reactive protein which may be 
related to one isolated from the cytoplasm. Investigations 
using this purified component have not been attempted in 
humans.
The A antigen has been well characterized regarding 
its applicability to human diagnosis. It has been partially 
purified and two of its components associated with its 
reactivity- It also has probably the best possibility as 
an immediate serologic tool. Even here, though, current 
preparations contain much extraneous material which could 
conceivably create cross^reactivity problems in the future.
The ethanol-precipitate antigens which have shown such 
superior results in the past have not been employed recently, 
nor have they been extensively characterized. This fraction 
may contain the reactive A antigen or other antigens 
deserving of study. Hopefully, the use of this technique 
can be encouraged as one starting point for isolation 
procedures.
The importance and isolation of enzymes and raannose
containing antigens have probably not received adequate
'
attention. An almost uniform identification of mannose in 
reactive preparations argues for purification procedures 
based on its presence.
Finally, use of hybridoma technology to produce 
antibodies specific for antigens of B. dermatitidis promises 
to improve our understanding of the organism and to help 
isolate purer antigenic fractions.
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The search for antigens of importance in the 
immunology of B. dermatitidis should not be confined to any 
one or all of the antigens discussed above. A variety of 
components will likely be necessary for complete 
understanding of the disease and for diagnostic use. It 
has been observed that ’’information of clinical value can 
be obtained from immunological reactions to several 
different antigens” (35), thereby encouraging continuous 
efforts to obtain as many as possible.
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CHAPTER 2
IDENTIFICATION OF THE ACTIVE PRECIPITIN 
COMPONENTS IN A PURIFIED PREPARATION 
OF THE A ANTIGEN OF BLASTOMYCES DERMATITIDIS,
ABSTRACT
A purified A antigen preparation of Blastomyces 
dermatitidis was determined to be composed of five major 
glycoprotein bands, visible with Coomassie blue and 
periodic acid^-Schiff staining of polyacrylamide gels. A 
minimum of 20 additional protein bands were detected 
using a silver stain which is 100 times more sensitive 
than the Coomassie method. Two components of this mixture 
were determined to be associated with the A antigenic 
activity of B. dermatitidis. Of several antigen preparations 
examined in Ouchterlony precipitation tests, those reactive 
with a reference antit-A antiserum contained the slowest 
moving of the "Coomassie blue" bands. The antigen 
preparations without precipitin reactivity lacked this 
protein band. Two protein bands were shown to disappear 
from an antigen preparation after incubation with an 
affinity gel linked to the reference anti-A serum. One of 
the bands was the slowest "Coomassie blue" band and the 
other was a fast-migrating protein detectable only with the
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silver stain. The characterization of the components 
responsible for the A antigenic activity has important 
applications in the production and standardization 
of serologic reagents for the diagnosis of blastomycosis,
INTRODUCTION
The A antigen of Blastomyces dermatitidis was first 
described in 1973 by Kaufman et al. (11) who found the 
activity in yeast broth filtrates. The antigen was 
subsequently used to identify B dermatitidis with 100% 
accuracy while giving no cross-reactions to various other 
fungi (12). A reference antiserum developed in 1979 (8) 
aided Green et In using anion-exchange chromatography
to purify an antigen fraction showing only A banding in 
Ouchterlony tests (9). This "purified" A antigen was 
found to be resistant to several proteases, nucleases, 
and to short periods of boiling. In this form, the antigen 
also showed promise as a serological tool in identifying 
active cases of blastomycosis by complement-fixation, 
skin-testing, ELISA procedures and Ouchterlony methods (9).
The continuing bane of fungal antigens as 
serological tools has been a combination of low sensitivity 
and high cross-reactivity. Although no cross-reactions 
with other fungi have been reported when the "A" antigen 
is used in Ouchterlony tests. Green et reported that 
such testing is only positive in 52% of known human cases. 
The same problem arose using complement-fixation where
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only 70% of the cases gave positive results. And although 
the ELISA procedure detected 92% of known cases, it had 
a high (.20%) rate of cross-reacting with various other 
fungal disease sera (9).
Crude extracts and impure antigen preparations 
have long been used in fungal serologic and epidemiologic 
studies. Such preparations have been shown to contain high 
numbers of common antigenic components which complicate 
the interpretation of immunologic tests (1,3,10). It 
is possibel that the usefulness of the "A" antigen of B. 
dermatitidis is still suboptimal because of contaminants 
in even the most recent pure preparations. It is, therefore, 
the purpose of this paper to more exactly identify those 
components associated with the "A" antigenic activity.
Gel electrophoresis, affinity chromatography, and 
comparisons of various antigenic preparations are presented 
to show that two specific proteins or glycoproteins can 
be identified as the active components of the "A" antigen.
The presence of these proteins in polyacrylamide gels 
can thus be used as a marker to identify antigen preparations 
which contain the "A" antigen, and as a standard against 
which the purity of various preparations may be measured.
MATERIALS AND METHODS
Antigen preparation. Cell cytoplasmic and cell-wall 
supernatant antigens were prepared by inoculating one liter 
amounts of BHI broth with a log phase culture of the 
respective isolate and incubating 3 days on a rotary shaker. 
The cells were killed by adding either formaldehyde 
(0.2% final concentration) or merthiolate (0.05% final 
concentration) and refrigerating for 48 hours. Whole cells 
were collected by centrifugation at 5000 g for 10 min and 
were washed 3 times with distilled water. A 50% suspension 
of cells was made in distilled water, added to an equal 
volume of 0.45-0.50 mm diameter glass beads, and broken 
for 90 sec in a C02^cooled Braun homogenizer. Cell debris 
was removed by centrifugation at 20,000 g for 30 min and the 
supernatant designated the "cytoplasmic” antigen. The 
cell wall debris was washed 3 times with distilled water, 
suspended 1:1 in distilled water, and stored at 4 C for 
at least 4 weeks. The water-soluble portion of this 
preparation was designated the "cell-wall supernatant" 
antigen. The cytoplasmic antigen from one isolate (SCB-2) 
was precipitated by adding either one or two volumes of 
95% ethanol (EtOH) to give a 50% and 67% EtOH-precipitate, 
respectively,
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The various antigens are listed in Table 1. The "OU" 
series was prepared in this laboratory. All other antigens 
were prepared and supplied by Sharon Harris and Stan 
Bauman of Immunomycologics, Inc., Norman, OK, The 
"Marshfield" isolates are clinical isolates from Marshfield, 
Wisconsin. The SOB and Davis isolates are also clinical 
isolates. All but two of the antigens, OU-S/CW and OU-D/CW, 
are cytoplasmic preparations. Purified "A"-antigen and 
reference "A'Vantiserum were supplied by Dr. W. K. Harrell 
of CDC. The preparation and purification of this antigen 
is described by Green et (9).
Ouchterlony immunodiffusion. Immunodiffusion 
was performed in prepared slides from Immunomycologics,
Inc., Norman, OK. Samples were delivered in 10 microliter 
amounts. Antisera were allowed to diffuse into the gel 
for 30 min before antigens were added to the test slides. 
Slides were read at 24 and 48 hr. Each was then developed 
for 5 min with phosphotungstic acid, according to the 
supplier's directions, in order to enhance visualization 
of faint bands. Rabbit anti-mouse IgG, anti-mouse IgM, 
and pure mouse IgC and IgM from myeloma lines MOPC-21 
and MOPC^104E were obtained from Bionetics Laboratory 
Products.
Polyacrylamide gel electrophoresis, PAGE was 
performed in an apparatus constructed as per the instructions 
of Ogita and Markert (15). This apparatus allowed the
TABLE 1 
ANTIGENS
ANTIGEN ISOLATE PREPARATION^ PROTEIN
(mg/ml)
OU-S SCB-2 formalin 1.0
OU-D Davis formalin 1.4
008BY CDC-A373 merthiolate 2.0
009BY CDC-A373 merthiolate 1.0
205B3 Marshfield #I formalin 0.7
008B3 Marshfield #1 formalin 0.6
007B3 Marshfield //I merthiolate 0.4
009B3 Marshfield #2 formalin 1.1
00AB3 Marshfield #2 merthiolate 0.5.
OU-S/CW SCB-2 formalin, cell-wall ND
OU-D/CW- Davis formalin, cell-wall ND
OU-S/50^ SCB-2 formalin, EtOH-ppt ND
OU-S/67 SCB-2 formalin, EtOH-ppt ND
1) Method of killing. Unless otherwise stated, all are cyto­
plasmic preparations,
2) Protein was measured by the method of Lowry as modified by 
Garvey et al. (7), or by the Coomassie blue dye-binding method 
of Bradford (2) as modified by Specter (18).
3) Designates the antigen fractions precipitated from the OU-S 
antigen by either 50% or 67% EtOH treatments.
4) ND = not done.
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formation of gels measuring 63 x 72 x 0.8 mm. The exact 
procedures and formulations of all solutions used in this 
study are tabulated in the same paper (15). Only two 
alterations were made —  first, glycerol was omitted 
from the acrylamide-bis solutions; and second, 1 ml of 
1% bromphenol blue was added directly to the upper reservoir 
instead of to each individual sample dilution. Running 
gels of 8%, 14%, or 20% acrylamide-bis were overlaid 
with a 4% stacking gel. Gels were electrophoresed until 
the dye front was between 3-5 ram from the bottom edge of 
the gel.
Proteins were visualized in the gels by staining 
for 1 hr in 0.1% Coomassie Blue R-250 in 50% TCA. Gels 
were then destained in 10% acetic acid for 1-2 hr at 60 C 
or for 24-48 hr at 25 C. In selected cases, 
proteins were stained by the modified silver stain of 
Oakley et (14), which is 100 times more sensitive than
the Coomassie blue method.
Gels were stained for carbohydrates by the periodic 
acid-Schiff (PAS) method of Zacharius et aJ. (19).
Affinity chromatography. Antibodies were linked to 
Affi-Gel 10 (Bio-Rad) according to the manufacturer's 
directions. After pre-washing, 30-40 mg of antibody were 
added to 4-5 ml of gel and allowed to react overnight at 
4° C with mild agitation. The antibody-linked gel was 
poured into a 1 cm diameter column, unabsorbed antigen 
washed out with Tris-HCl buffer (0.1 M, pH 8.0, 0.15-0.5 M
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NaCl), and allowed to stand in the same buffer for 1 hr to 
saturate any remaining sites. The gel was washed with 
glycine-HCl elution buffer (0.05 M, pH 2.4) and rewashed 
with Tris buffer. Antigen (1.3-1.5 mg in 2.5 ml Tris) 
was added and incubated for 1 hr at room temperature. 
Unadsorbed antigen was washed out with Tris buffer, and 
adsorbed antigen removed by the glycine-HCl buffer. The 
gel was immediately rewashed with Tris buffer and stored 
at 4 C.
RESULTS
Ouchterlony Precipitation with Anti-A Reference Serum.
Precipitin lines of identify were formed between 
the purified A antigen and the following antigen preparations; 
OU-S, OU-S/CW (slight), OU-D, OU-D/CW (very slight),
205B3 (slight), OU-S/50, and OU-S/67. Lines were absent 
in the following antigen preparations: 008BY, 009BY,
00AB3, 009B3, 007B3, and 008B3 (fig, 1). Close inspection 
of the line formed midway between the purified A antigen 
and the anti-A reference serum revealed it to be composed 
of two very close lines which are fused. This can be most 
clearly seen in the photograph of the reactions involving 
the two ethanol precipitate antigens, although the same 
phenomenon seemed to occur with all reactive preparations, 
(fig. 1).
PAGE of Purified A Antigen 
Purified A antigen was electrophoresed in 14% and 
20% polyacrylamide gels and stained for protein by the 
Coomassie blue and silver methods. The results are shown 
in Figures 2 and 3. Only five protein bands appeared 
when.stained with Coomassie blue, with Rf values between 
0.19 and 0.29 in the 14% gel and between 0.10 and 0.17
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Figure 1. Precipitin bands between anti-A reference serum and various 
antigen preparations. The center wells of the A and B templates, and 
the #1 well of the C template contained anti-A serum. Template A 
tested these antigens: well #1, purified A antigen; #2, 205B3; #3,
00AB3; #4 009B3; #5, 007B3; //6, 008B3. Template B tested these antigens: 
well #1, purified A antigen; #2, OU-S; #3, OU-S/CW; #4, 009BY; #5, 
OU-D/CW; #6, OU-D. Template C tested: well #2, OU-S/SO; #5, OU-S/67.

Figure 2. Protein stain of 14% gels. Track #1, OU-S; #2, OU-S after 
passage through affinity column containing anti-A antigen reference 
serum; #3, purified A antigen. Gel A, Coomassie blue stain; gel B, 
silver stain. Arrow locates common protein band which is partially 
removed by affinity chromatography from the OU-S preparation in 
track #2, gel A.
Figure 3. Protein stain of 20% gels. Arrangement as in Figure 2. 
Arrow locates common protein band removed by affinity chromatography 
from the OU-S preparation in track #2, gel B.
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in the 20% gel. The silver stain revealed a minimum of 
25 well-defined protein bands with the most rapidly moving 
band having an Rf of 0.54 and 0.27 in the 14% and 20% 
gels, respectively. PAS staining revealed 5 carbohydrate 
bands corresponding to the 5 seen with Coomassie blue.
The silver stain also revealed numerous a-ditional bands 
in the OU-S preparation which reproduced photographically 
as an almost solid black track.
Comparison of Purified A Antigen With Other Preparations.
Gel scans of polyacrylamide gels are shown in 
Figures 4 and 5. These gels compare the purified A 
antigen with the OU-S preparation, which reacted with 
anti-A serum in Ouchterlony tests, and with the 008BY 
preparation, which was non-reactive. Both the 14% and 
20% gels revealed only one common band between the reactive 
OU-S preparation and the purified A antigen. This 
particular band appeared only faintly, if at all, in the 
non-reactive 008BY preparation, and then only in the 
20% gel. The correspondence between the slowest-moving 
protein of the purified A antigen (in the Coomassie-stained 
gels) and the largest band in OU-S can be seen in Figure 2.
Several other antigens were electrophoresed to 
compare the presence or absence of this particular band 
with the reactivity of the preparations in Ouchterlony 
precipitation tests. These gels are shown in Figures 6 - 8 .  
In all cases, presence or absence of the marked band
Figure 4. Gel scan of 14% gels stained with Coomassie blue. Antigen 
preparations are; A = OU-S; B = purified A antigen; C = 008BY. Arrows 
designate bands held in common.
ABSORBANCE: 550 NM
Figure 5. Gel scan of 20% gels stained with Coomassie blue. Legend 
as in Figure 4.
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Figure 6. Coomassie blue stain of 20% gel. Track #2, OU-S; #3, OU-D; 
#4, 205B3; #5, 008BY; #6, OU-S/CW; #7, OU-D/CW. Arrow locates position 
of the "OU-S/A-antigen" common protein band.
Figure 7. Coomassie blue stain of 20% gel. Track #1, 008BY; #2, 009BY; 
#3, 00AB3; #4, 009B3; #5, 007B3; #6, 008B3. Arrow locates the position 
at which the "OU-S/A-antigen" common band should appear.
2 3 4 5 6 7
1 2 3 4 5 6
Figure 8. Coomassie blue stain of 20% gel. Track #1, OU-S; #2, OU-S/50; 
#3, OU-S/67; #4, purified A antigen. Arrow locates the "OU-S/A-antigen” 
common protein band.
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paralleled the presence or absence of precipitin reactivity 
to the anti-A reference sertun. The corresponding bands 
in OU-D and 205B3 in Figure 6 were much lighter than 
in OU-S and were not clearly reproduced photographically. 
The A antigenic activity was shown to be precipitated 
with ethanol treatment (Fig, 8).
In addition, these results demonstrate that 
lot^to-lot variation of antigen preparations may be 
absent (008By-vs-009BY, Fig 7), or slight (007B3-vs-00AB3, 
Fig. 7). Strain^to-strain variations may occur in 
relatively few protein bands (0O7B3-vs-0OAB3 and 008B3-vs- 
009B3, Fig, 7, and OU-S-vs-OU-D, Fig. 6), or in many 
bands (OUr-S or OU-D vs any antigen in Fig. 7). Preparation 
by killing with formalin versus merthiolate yielded only 
minor differences (007B30vs-008B3 and O0AB3-vs-O09B3,
Fig. 7).
Affinity Chromatography
The removal of protein bands from OU-S by affinity 
chromatography through an anti-A-linked gel is shown in 
Figures 2 and 3. In both figures, the non-adsorbed OU-S 
had been adjusted to the same protein concentration as the 
applied OU-S. Figure 2 most clearly shows the reduction 
of the slowest-moving band of the A antigen from OU-S 
(Coomassie blue-stained gel). This band is the one 
previously shown to be common to both preparations (Figs.
4 and 5). An additional, rapidly-migrating protein band,
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which appeared only after silver staining, was completely 
absent from the antigen exposed to the affinity gel but 
was present in both the OU-S antigen before application 
to the Gel and in the purified A antigen (fig. 3).
DISCUSSION
Although the A antigen of Blastomyces dermatitidis 
has been shown to be of use in the serologic diagnosis 
of blastomycosis (9, 11, 12, 16), the antigen itself 
has been poorly characterized. The purification by 
ion exchange chromatography of an antigen fraction 
containing reactivity to a reference anti-A serum (8, 9) 
has allowed us to more exactly characterize the components 
responsible for the A antigenic activity.
The purified preparation of Green et aJ. (9) 
consists of at least 25 proteins and glycoproteins, as 
determined by a combination of Coomassie blue, PAS, 
and silver staining of polyacrylamide gels. Such a 
mixture may be the reason that cross-reactions with other 
mycotic disease sera continue to occur in the highly 
sensitive ELISA procedure (9). The use of a mixture 
may be appropriate in less sensitive techniques, such as 
Ouchterlony precipitation, but an unacceptable increase 
in false negative reactions also occurs (9). As long 
as extraneous material is included in antigen preparations, 
the absence of cross-reactions cannot be guaranteed.
Although previous reports suggest that precipitation
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tests yield a single band between the A antigen and anti-A 
serum, we have noted that the reaction is more likely 
one giving two fused bands. This correlates well with the 
findings that two specific components, identified by 
comparison with other antigen preparations and by affinity 
chromatography, are involved in the A antigenic activity.
The identification of these two components opens 
the way to their further purification, using polyacrylamide 
gel electrophoresis as a sensitive indicator of purity.
In the past, Ouchterlony tests have been the primary 
method used to assay various antigen fractions for the 
presence of the A antigen. Although this may be useful 
as a preliminary test, a more sensitive assay is needed 
if very pure preparations are to be produced. Huppert 
et al. (10) have suggested the use of two-dimensional
electrophoresis as a tool for both standardizing and 
assessing the purity of antigen preparations. The 
major drawbacks to this use of the method include the 
amount of time and material required to perform the 
test, its relative insensitivity, and its reliance on 
an antigen-antibody reaction. This latter is restricting 
since a large quantity of antibody must be used, and since 
antigens of possible significance may go undetected if 
specific antibody is unavailable. The staining of proteins 
in polyacrylamide gels is a rapid and very sensitive 
procedure, especially if the new silver stain is employed.
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and many samples may be compared in detail. For comparative 
purposes, a standard is now available using the purified 
A antigen with knowledge of its specific reactive components. 
Hopefully, much purer preparations will soon become available.
The location of the A antigen has also been addressed. 
Kaufman et al. (11) first located it in yeast culture 
filtrates. It has since been most commonly prepared by 
extracting whole yeast cells with water or saline over a 
several-week period (8, 9, 12). Reference anti-A serum 
has been reported to be adsorbed by yeast cell walls but 
not by cytoplasmic preparations (9). These previous 
investigations have been performed with only two isolates of 
B. dermatitidis, A295 and A373. We have verified that the 
A antigen is absent, or present in insignificant amounts, 
in the cytoplasm of A373 (antigens 008BY and 009BY).
However, other isolates have shown significant amounts of 
A antigen in cytoplasmic preparations (OU-S and OU-D). This 
has two ramifications. First, preparation of large 
quantities of the A antigen can be made more quickly by 
breaking whole cells, although contamination with extraneous 
material may be greater than in aqueous extracts. Second, 
the precise location and function of the A antigen remains 
in doubt, and several isolates must be included in future 
studies examining these questions.
The finding that the A antigen can be precipitated 
by ethanol may have some historical, and perhaps practical,
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implications. As early as 1911, Davis (4) isolated a 
fraction from yeast cytoplasm by ethanol precipitation 
which yielded a fairly sensitive precipitin antigen for 
infected guinea pig serum. Many investigators have 
since employed ethanol precipitation to isolate surprisingly 
sensitive antigens (K, D. Young, Ph.D. thesis, University 
of Oklahoma, Norman, 1980). Antigens from yeast culture 
filtrates have been reported to detect 100% of infected 
guinea pigs or rabbits by skin test while having 0% 
cross-reactions with animals having other mycoses (5, 6,
13), In a recent study, Rippon ^  reported successfully 
detecting 90% (18 of 19) known human cases by Ouchterlony 
precipitation, with 0% (0 of 40) cross-reactions with sera 
from patients having other systemic mycoses (17). None 
of these preparations was characterized in depth, and the 
possibility that they contained what is now termed the "A 
antigen" seems quite high. Incorporation of an ethanol 
precipitation step may therefore be useful in future 
purification schemes.
Rippon et aJ.. have noted that without the tools of 
skin-test or complement-fixation antigens for epidemiological, 
diagnostic, and prognostic use, "we are at least 50 years 
behind in our defining the disease blastomycosis (17)."
Much of the problem has been due to impure antigen preparations 
and an imprecise understanding of the reactive agents. 
Hopefully, the identification of particular reacting 
components will help alleviate some of the problems involved 
in closing such a large gap.
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CHAPTER 3
PRODUCTION AND CHARACTERIZATION OF HYBRIDOMA-DERIVED 
ANTIBODIES TO BLASTOMYCES DERMATITIDIS.
ABSTRACT
A hybridoma cell line was isolated which produced 
monoclonal antibody to one protein component of a yeast-phase 
cytoplasmic antigen of Blastomyces dermatitidis. The IgM 
antibody product was characterized by immunodiffusion, 
autoradiography of polyacrylamide gels, and cellulose 
acetate electrophoresis. By attaching the antibody to an 
affinity gel, one major protein band was identified as the 
antigen for which the antibody was specific. The usefulness 
of this approach to serologic analysis of fungal pathogens 
is discussed.
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INTRODUCTION
In the past few years a technique has been developed 
which allows the production of large quantities of monoclonal 
antibodies (8, 10, 12). Such antibodies are extremely 
pure and are specific for only one antigenic determinant.
They can, therefore, be used as extremely sensitive probes 
or isolation tools for their respective antigen.
The production of these hybridoma-derived antibodies 
for pathogenic fungi was first reported for Blastomyces 
dermatitidis (K. D. Young and H. W. Larsh, Abstr. Ann. Meet 
Am. Soc. Microbiol., 1980, FI, p. 319) and for Cryptococcus 
neoformans (N. K. Hall and R. Blackstock, Abstr. Ann. Meet. 
Am. Soc. Microbiol., 1980, F2, p. 319). The former report 
outlined the optimum conditions for production of hybridomas 
when using B. dermatitidis. The latter reported isolation 
of 9 hybridomas producing antibodies having differing 
specificities to cells of C^ neoformans, Histoplasma 
capsulatum, and Coccidiodes immitis. Neither of these 
previous reports included a characterization of the antigens 
for which the antibodies were specific.
We report the isolation of a hybridoma line 
secreting antibody to a cytoplasmic preparation of B.
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dermatitidis. By linking this antibody to an affinity 
gel, the protein for which the antibody is specific was 
purified and characterized by polyacrylamide gel 
electrophoresis. The implications of this technique for 
the study of the pathogenic fungi is discussed.
MATERIALS AND METHODS
Antigen preparation. A cytoplasmic fraction from B. 
dermatitidis cells broken by glass beads in a Braun 
homogenizer was supplied by Sharon Harris and Stan Bauman 
of Immunomycologics, Inc., Norman, Ok. This "009BY" preparation 
was derived from merthiolate-killed yeast cells of the CDC 
isolate, A373, and contained 1.0 mg/ml protein.
Production of hybridomas. C57BL/6J mice (Jackson 
Labs) were injected with approximately 5 x 10^ formalin-killed 
B. dermatitidis yeast cells at 2-week intervals for 8 weeks.
The first three injections were I.P., and the last, I. V. 
in the tail vein. Mice were sacrificed 3 days after the 
final injection and their spleens removed.
The following hybridization procedure is a composite 
drawn from Kennett (7), Shulman (13), and Gefter (5).
Spleens were placed in sterile Eagle’s Minimal Essential 
Medium (EMEM) without calcium and magnesium and minced 
through wire mesh screens into tissue-culture dishes. The 
cell suspension was gently drawn into a syringe, dispenses 
through 200, 220, and 260 needles, and centrifuged at 
400-5000 for 10 min. The cell pellet was suspended in 5 ml 
of 4 C 0.17 M NH4C1 for 10 min, diluted with 10 ml Dulbecco's
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Modified Eagle's Medium (DMEM), pelletted, washed twice more 
with DMEM, and resuspended in 5 ml of EMEM-fusion medium.
NS-1 myeloma cells (Hybritech, Inc.) were maintained 
in DMEM plus 8-azaguanine (1 0 "^ M) and cells in mid-log 
were used for fusions. NS-1 and spleen cells were combined 
in approximately a 1:10 ratio, pelletted, washed twice with 
EMEM-fusion, and repelletted. All supernatant was removed 
and the pellet loosened by tapping. A 30% PEG solution in 
EMEM-fusion had been previously adjusted to pH 7.4-7.6 
and maintained at 37 C. The pelletted cells were covered 
with 0.2 ml of this 30% PEG solution for 8 min, during which 
the pellet was centrifuged at 400-500G for 3-6 min. The 
pellet was then gently suspended in 5 ml of EMEM-fusion medium, 
mixed in an additional 5 ml of EMEM-fusion, centrifuged, 
and washed once in the same medium. The pellet was suspended 
in 15-16 ml of DMEM plus hypoxanthine (10“^ M) and thymidine 
(1.6 X 10"4 M),and 50 microliters were distributed to each 
of the 60 interior wells of 5 microtiter plates (Linbro).
After incubating 24 hr in a 5% CO2 atmosphere, 50 microliters 
of "HAT" selective medium was added to each well, and 100 
microliters of DMEM plus hypoxanthine and thymidine added 
after incubating 7 days. Colonies appeared 10-20 days after 
the last addition of medium and were transferred to new medium 
in microtiter dishes, then to larger culture dishes if found 
to be producing antibody.
Ascites fluid containing hybridoma antibodies was
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produced by injecting at least 10® hybridoma cells I.P. 
into Pristane-primed BALB/C mice. Fluid was drawn after 
10-14 days. Hybridoma cells were frozen by suspending to 
5-10 X 10® cells/ml in cold 5% dimethylsulfoxide in fetal 
calf serum (FCS) and cooling first to -20 C for 1 hr. then 
transferring to a r-70 C freezer. Antibodies from selected 
hybridoma culture supernates were partially purified by the 
50% ammonium sulfate precipitation method of Jonak (14).
The precipitate from 500 ml of supernate was resuspended 
in 7 ml of PBS, pH 7.2, and dialyzed against the same.
Maintenance medium was composed of DMEM containing 
NaHCOS and glutamine, 10% FCS, 100 units/ml Penicillin, 
and 100 micrograms/ml streptomycin. EMEM-fusion medium was 
EMEM without calcium and magnesium, pH 7.4-7.6. All tissue 
culture media was obtained from GIBCO. Polyethylene glycol 
was obtained from Koch-Light, Ltd. All other chemicals 
were from Sigma,
The Blastomyces-specific hybridoma line has been 
placed with Dr. N. K. Hall of the University of Oklahoma 
Health Sciences Center, Oklahoma City.
ELISA procedure. Hybridoma antibodies specific for 
B. dermatitidis were detected by enzyme-linked 
immunosorbant assay (ELISA). Antigen was suspended in 
carbonate-bicarbonate buffer, pH (Dynatech Labs, Inc.) 
overnight at 4° C. Plates were rinsed 3 times in 3 rinses 
in PBS, Supernatants (0.1 ml) from cultures having 
hybridoma growth were added, incubated 1 hr at room
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temperature, and washed 3 times in PBS, Peroxidase-linked 
goat anti-mouse IgG (heavy and light chain-specific,
Bionetics) was diluted 1:100, 0,1 ml added to each well, 
nncubated for 1 hr at room temperature, and washed 3 times 
in PBS. The reagent solution of 0.15% H2O 2 and 0.1% 
0-phenylenediamine was added in 0.1 ml amounts to each 
well, incubated 1 hr at room temperature, and read 
spectrophotometrically at 492 nm. Controls consisted of 
wells containing no antigen or antigen plus uninoculated 
medium, medium from NS-1 cells alone, or normal mouse serum.
Autoradiography of polyacrylamide gels. Localization 
of immunoglobulins in polyacrylamide gels was accomplished 
by the method of Bonner and Laskey (1). Hybridoma or myeloma 
cells were suspended to a final concentration of 0.1-1.0 
X 10® cells/ml in 1.0 ml DMEM plus hypoxanthine and thymidine. 
3H-leucine was added to give 1.0-4.0 micro-Ci/ml. The 
suspension was incubated 24 hr at 37° in 5% CO2 . The cells 
were removed by centrifugation and the supernatant stored 
at -20° C.
Portions of the supernatants were separated on SDS 
polyacrylamide gels, and the gels fixed in 50% TCA for 30 
min. The gels were then soaked in two successive 20X 
volumes of dimethyl sulfoxide (DM80) for 30 min each. The 
gels were next placed in a 4X volume of 22.2% (w/v) 2,5- 
diphenyloxazole in DM80 for 3 hr, after which they were soaked 
in a 2OX volume of distilled water for 1 hr. The gels were 
dried on Watman #4 paper in a Bio-Rad gel dryer for 1-2 hr
94
and exposed to Kodak X-OMAT R film at -70° C for 3-^ 7 days.
The X-'ray film is more sensitive if pretreated with light 
before exposing the gels (11). Pretreatment consisted of 
a 20-sec exposure to a yellow 20 watt "bug-light" placed 
approximately 20 feet from the film. The bulb was shielded 
with cardboard containing a 1" slit through which the 
light could pass. The film was developed according to the 
manufacturer’s directions (9).
Cellulose acetate electrophoresis. Electrophoresis 
was performed in a Beckman Microzone apparatus, using 
Millipore membranes. One microliter samples were applied 
and electrophoresed at 250V for 20 rain in 0.05 barbital 
buffer, pH 8,6. Proteins were stained in 0.4% amido black 
in 7% acetic acid, destained with 5% acetic acid, and 
cleared with 30% cyclohexanone in 95% ethanol.
Other procedures. Polyacrylamide gel electrophoresis, 
Ouchterlony immunodiffusion, and affinity chromatography 
have been described previously (K. D. Young, Ph.D. Thesis, 
Chapter 2).
RESULTS
Of the hybridomas isolated, one (OU31/B6) produced 
absorbance reading 6 times that of control values in the 
ELISA procedure, and was selected for further characterization. 
Analysis of the culture supernatant and ammonioum 
sulfate-precipitated.fractions by Ouchterlony immunodiffusion, 
cellulose acetate electrophoresis, and autoradiography 
indicated that 0U32/B6 produced IgM.
The autoradiography results in Figure 1 show that 
OU32/B6 produced only IgM. Heavy IgG chains are absent 
from the supernatant. In addition, the hybridoma cells 
secreted antibody in much greater amounts than may have 
been present in the original myeloma line. This is clear 
from tracks #2 and #4 in the gel (Fig. 1). Use of ^H-leucine 
in amounts greater than 1 uCi/10)6) cells reduced the amount 
of antibody secreted (tracks #3 and #5, Fig. 1), probably 
because of lethal effects.
Ascites fluid contained IgM and IgG as determined
by Ouchterlony tests. A precipitin band formed between
this preparation and the 009BY antigen (data not shown).
This band was not present when the ammonium sulfate-precipitated
antibody was tested and so may be an artifact due to other
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Figure 1. Autoradiography of hybridoma antibodies in polyacrylamide 
gels. Antibodies were separated in a 14% SDS polyacrylamide gel. 
Myeloma (NS-1) and hybridoma (0U32/B6 and OU32/C1) cells were incubated
3
in various concentrations of H-leucine as follows: lane #1, NS-1 +
1.0 uCi; #2, OU32/C1 + 1.0 uCi; #3, 0U32/C1 + 2.0 uCi; #4, 0U32/B6 +
1.0 uCi: #5, OÜ32/B6 +4.0 uCi. Film was exposed to the gel for 165 
hours before developing. The top, middle, and lower arrows locate the 
position of IgM heavy chains, IgG heavy chains, and light chains, 
respectively, as determined in a separate gel stained for protein.
Figure 2. PAGE analysis of protein eluted from hybridoma antibody- 
linked affinity column. Proteins were electrophoresed through a 14% 
polyacrylamide gel and stained for protein by the silver method. Lane 
#1 contains 009BY antigen (100 ug/ml). Lane #2 contains the material 
eluted from the affinity column. The eluate was concentrated lOOX 
prior to electrophoresis. The arrow locates the position of the 
eluted band.
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components in the ascites fluid. Therefore, the 
precipitated antibody was used in subsequent procedures.
Affinity chromatography using the ammonium 
sulfate-precipitated antibody was successful in purifying 
one component from the 00937 antigen preparation as shown 
in Figure 2. The location o# this band relative to the 
other protein components of the antigen preparation is 
shown in Figure 3. The scan of Fig. 3 and the silver 
stain of Fig. 2 were différant gels, processed separately, 
and so a number of bands in Fig. 3 do not appear in the 
photograph of Tig. 2.
Figure 3. Gel scan of 009BY antigen preparations separated on a 14% 
native polyacrylamide gel, stained with Coomassie blue, and destained 
in 10% acetic acid. A small "c" indicates bands also staining for 
carbohydrate with FAS. The small dot indicates a non-specific, opaque 
"junk" band which appears in unstained gels. The arrow designates the 
protein which corresponds to the band eluted from an OU32/B6 antibody- 
linked affinity column.
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DISCUSSION
The progression of blastomycosis in man and 
experimental animals has been difficult to assess, 
primarily because suitable immunologic monitoring 
techiques have been unavailable. Although the refinement 
of the A and ASWS antigens (4, 6) offers a great improvement 
in the diagnosis of blastomycosis, they are not necessarily 
the only antigens of use in diagnosis or in the study of 
the disease's development.
Studies of cross-reactions among patients with 
diseases caused by these three organisms indicate that 
different antigens of B. dermatitidis may be involved in 
the elicitation and detection of different immunologic 
properties, in this case between skin tests and lymphocyte 
transformation (3). It is possible that protective or 
diagnostic components may be absent in some preparations 
or overshadowed by other antigens (2). In either case, 
such relevant antigens could escape notice, especially 
since all current antigen and antibody preparations contain 
such a multiplicity of individual components.
The development of a technique to produce large 
quantities of monospecific antibodies by fusing a tumor
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cell line and spleen cells from an immunized animal is 
already revolutionizing serological analyses (8, 10, 12).
In the present report we have applied this technology to 
isolate a hybridoma cell line which produces IgM antibody 
against a cytoplasmic preparation of Blastomyces 
dermatitidis.
The antigen for which this antibody is specific 
has been isolated by affinity chromatography. Gel 
electrophoresis has revealed this preparation to contain 
one protein band. The development of such a cell line allows 
the isolation and characterization of this antigen to be 
standardized. This makes available for the first time a 
monospecific antibody to, and a single component antigen 
of B. dermatitidis.
Charlotte Campbell observed that "accurate serologic 
analysis...can not be achieved except by the isolation and 
characterization of each antigenic component an organism 
produces, related as well as unrelated, and the further 
correlation of these components’ activities with antibodies 
produced throughout all stages of an infection (3)." Not 
until 20 years later has this ideal finally become achievable. 
Hopefully, a "library" of hybridomal lines can be developed, 
each producing an antibody to a different component of the 
pathogenic fungi. Such a library will prove invaluable in 
increasing not only our diagnostic capabilities, but also 
our ability to study the disease process in greater detail.
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